SecBot SecBot
8-K ·Filed Jun 11, 2026

XRAY

DENTSPLY SIRONA Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0000818479-26-000200
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

Monitor next quarterly earnings for any strategic or financial changes under the new CFO. No immediate trading catalyst from this routine appointment.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$10.14
T+0 close · Jun 11, 2026 · via day close
Latest settled
+12.23%
T+60 · $11.38
Vs SPY
+7.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $10.14entry
  2. T+1 · 5mo ago −0.49%α −1.03% · $10.09
  3. T+5 · 5mo ago −1.08%α −1.52% · $10.03
  4. T+20 · 4mo ago +17.26%α +15.37% · $11.89
  5. T+60 · 2mo ago +12.23%α +7.83% · $11.38
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

DENTSPLY SIRONA appointed John C. Fortson as EVP & CFO, effective July 20, 2026, replacing the prior CFO. Fortson brings extensive public company CFO and CEO experience, most recently at Kymera International and previously at Ingevity and AAR Corp. The filing is a routine officer appointment with no financial data or guidance provided.

Key Facts

  • John C. Fortson appointed EVP & CFO, effective July 20, 2026
  • Annual base salary of $780,000, target annual bonus of 85% of base salary
  • Sign-on cash payment of $500,000 payable in February 2027
  • Sign-on equity award with target grant date fair value of $700,000 (60% premium stock options, 40% RSUs, three-year ratable vesting)
  • Eligible for annual equity award with target grant date fair value of $2,500,000 beginning in 2027
  • Fortson has over 25 years of experience, served as CFO/CEO at multiple public companies

Financial Impact

No financial impact disclosed. Compensation package includes $780,000 base salary, 85% target bonus, $500,000 sign-on cash, $700,000 sign-on equity, and $2,500,000 annual equity target.

Risk Factors

  • No financial guidance or performance metrics provided in this filing
  • CFO transition may cause short-term uncertainty, though Fortson's experience is extensive

Market Snapshot

Exchange
Nasdaq
Sector
Dental Equipment & Supplies
Analyst Consensus
36% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000818479-26-000200
Document: johncfortsonofferletter.htm0000818479-26-000200
Document: xraycfoappointmentpressr.htm0000818479-26-000200
Document: 0000818479-26-000200-index-headers.html0000818479-26-000200
Document: 0000818479-26-000200-index.html0000818479-26-000200
Document: 0000818479-26-000200.txt0000818479-26-000200

US Market Status

Market Closed · Opens in 6h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026